Syngenta obtains non-exclusive IP license for CRISPR-Cas9

Syngenta has attained a non-exclusive IP license from the Broad Institute of MIT and Harvard for CRISPR-Cas9 genome-editing technology for agricultural applications.
 
CRISPR-Cas9 genome editing technology complements Syngenta’s already robust plant breeding innovation toolbox. Syngenta is applying this technology in multiple crops, including corn, wheat, tomato, rice and sunflower.



“Gaining access to CRISPR-Cas9 technology will allow us to accelerate the rate of innovation in the development of new plant varieties, and bring novel traits into the hands of growers faster, and with greater efficiency,” said Michiel van Lookeren Campagne, global head of seeds research at Syngenta. “Using this advanced technology will help us deliver on the 21st century food production challenges.”

For more information:
www.Syngenta-US.com

Publication date :



Receive the daily newsletter in your email for free | Click here


Other news in this sector:


© HortiDaily.com 2018